NCT06099548 - Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions

High-Risk Percutaneous Coronary Intervention

Interventions

DEVICE

The Elevate™ System

The Magenta Elevate™ is a temporary (≤ 6 hours) ventricular support device indicated for use during high-risk percutaneous coronary interventions (HR-PCI) performed electively or urgently in hemodynamically stable patients, with severe coronary artery disease.

Trial Locations (2)

Unknown

"Israeli-Georgian Medical Research Clinic Helsicore", Tbilisi

Tbilisi Heart and Vascular Clinic, Tbilisi